# Peplin clinical trials: 29 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 29 trials with Peplin as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Peplin: 29 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/peplin

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 29
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 29, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 30, 2011 | NCT01325688 | PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities | Peplin | Phase 2 | Completed | Superficial Basal Cell Carcinoma | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01325688) |
| February 24, 2011 | NCT01302925 | PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects | Peplin | Phase 1 | Completed | Healthy, Actinic Keratosis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01302925) |
| October 5, 2010 | NCT01214577 | Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, 0.015%, in Patients With Photo-damaged Skin | Peplin | Phase 2 | Completed | Photo-damage | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01214577) |
| October 5, 2010 | NCT01214564 | Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis | Peplin | Phase 2 | Completed | Seborrheic Keratosis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01214564) |
| October 5, 2009 | NCT00989313 | A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the... | Peplin | Observational | Completed | Actinic Keratosis | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00989313) |
| August 6, 2009 | NCT00953732 | A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies | Peplin | Observational | Completed | Actinic Keratosis | 117 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00953732) |
| August 6, 2009 | NCT00952783 | A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study | Peplin | Observational | Completed | Actinic Keratosis | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00952783) |
| July 21, 2009 | NCT00942604 | A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the... | Peplin | Phase 3 | Completed | Actinic Keratoses | 203 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00942604) |
| June 10, 2009 | NCT00917306 | A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head... | Peplin | Phase 3 | Completed | Actinic Keratosis | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00917306) |
| June 8, 2009 | NCT00916006 | A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head... | Peplin | Phase 3 | Completed | Actinic Keratosis | 269 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00916006) |
| June 8, 2009 | NCT00915551 | A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head... | Peplin | Phase 3 | Completed | Actinic Keratosis | 278 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00915551) |
| February 26, 2009 | NCT00852137 | A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal... | Peplin | Phase 2 | Completed | Actinic Keratosis | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00852137) |
| February 25, 2009 | NCT00850811 | A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers | Peplin | Phase 1 | Completed | Actinic Keratosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00850811) |
| February 25, 2009 | NCT00850681 | A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers | Peplin | Phase 1 | Completed | Actinic Keratosis | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00850681) |
| August 27, 2008 | NCT00742391 | A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the... | Peplin | Phase 3 | Completed | Actinic Keratoses | 255 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00742391) |
| June 18, 2008 | NCT00700063 | A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or... | Peplin | Phase 2 | Completed | Actinic Keratosis | 265 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00700063) |
| April 17, 2008 | NCT00659893 | Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 | Peplin | Phase 1 | Completed | Actinic Keratosis | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00659893) |
| October 19, 2007 | NCT00546611 | The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s) | Peplin | Phase 1 | Withdrawn | Warts | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00546611) |
| October 16, 2007 | NCT00544297 | A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand | Peplin | Phase 2 | Completed | Actinic Keratosis | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00544297) |
| October 16, 2007 | NCT00544258 | Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 | Peplin | Phase 1 | Completed | Actinic Keratoses | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00544258) |
| February 7, 2007 | NCT00432185 | To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC | Peplin | Phase 2 | Completed | Superficial Basal Cell Carcinoma | 117 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00432185) |
| January 26, 2007 | NCT00427050 | A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel | Peplin | Phase 2 | Completed | Actinic Keratoses | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00427050) |
| September 13, 2006 | NCT00375739 | Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses | Peplin | Phase 2 | Completed | Actinic Keratosis | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00375739) |
| July 28, 2006 | NCT00357916 | Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design | Peplin | Phase 1 | Completed | Healthy | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00357916) |
| May 24, 2006 | NCT00329121 | Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ | Peplin | Phase 2 | Completed | Carcinoma, Squamous Cell | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00329121) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 7 |
| Phase 2 | 14 |
| Phase 3 | 5 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 28 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Keratosis, Actinic | 21 |
| Melanosis | 3 |
| Carcinoma, Basal Cell | 2 |
| Warts | 1 |
| Carcinoma, Squamous Cell | 1 |
| Bowen's Disease | 1 |
| Keratosis, Seborrheic | 1 |
| Keratosis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Water delivery companies in the United States](https://specstream.ai/data/businesses/water-delivery-companies/united-states)
- [Medical supply stores in the United States](https://specstream.ai/data/businesses/medical-supply-stores/united-states)
- [Contract law firms in the United States](https://specstream.ai/data/businesses/contract-law-firms/united-states)
- [Syrian restaurants in the United States](https://specstream.ai/data/businesses/syrian-restaurants/united-states)
- [Investment management firms in the United States](https://specstream.ai/data/businesses/investment-management-firms/united-states)
- [Builders in the United States](https://specstream.ai/data/businesses/builders/united-states)
